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Abstract
Pore-forming toxins (PFTs) constitute the single largest class of proteinaceous bacterial virulence factors and are made by
many of the most important bacterial pathogens. Host responses to these toxins are complex and poorly understood. We find
that the endoplasmic reticulum unfolded protein response (UPR) is activated upon exposure to PFTs both in Caenorhabditis
elegans and in mammalian cells. Activation of the UPR is protective in vivo against PFTs since animals that lack either the ire-1-
xbp-1 or the atf-6 arms of the UPR are more sensitive to PFT than wild-type animals. The UPR acts directly in the cells targeted
by the PFT. Loss of the UPR leads to a normal response against unrelated toxins or a pathogenic bacterium, indicating its PFT-
protective role is specific. The p38 mitogen-activated protein (MAPK) kinase pathway has been previously shown to be
important for cellular defenses against PFTs. We find here that the UPR is one of the key downstream targets of the p38 MAPK
pathway in response to PFT since loss of a functional p38 MAPK pathway leads to a failure of PFT to properly activate the ire-1-
xbp-1 arm of the UPR. The UPR-mediated activation and response to PFTs is distinct from the canonical UPR-mediated
response to unfolded proteins both interms of its activation and functional sensitivities.These data demonstratethatthe UPR,
a fundamental intracellular pathway, can operate in intrinsic cellular defenses against bacterial attack.
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Introduction
Pore-forming toxins (PFTs) are the single most prevalent protein
virulence factor made by disease-causing bacteria and are
important for the virulence of many important human pathogens
including Staphylococcus aureus, Streptococcus pyogenes, Clostridium
perfringens, and Aeromonas hydrophilia [1,2]. Crystal (Cry) toxins
produced by the invertebrate pathogen Bacillus thuringiensis (Bt) are
a large family of PFTs that target the intestinal cells of insects and
nematodes [3,4,5]. The fact that some Cry proteins target
nematodes, in particular C. elegans, has been exploited to provide
the only in vivo genetic model for studying PFTs. This system led to
the discovery of the first signal transduction pathway that protects
cells against PFTs, the p38 mitogen-activated protein kinase
(MAPK) pathway, which has been confirmed in mammalian cells
[6,7]. There is growing evidence that the response of cells to PFTs
is, however, complex and there is a great deal yet to learn [8].
The unfolded protein response (UPR) of the endoplasmic
reticulum (ER) is a fundamental stress response used by eukaryotic
cells to match protein synthesis demand to its capability to fold
proteins within the ER to maintain cellular homeostasis [9]. In C.
elegans and other animals there are three transducers that signal
from the ER to activate this response. These three distinct arms of
the UPR are mediated by IREI, ATF6, and PERK in mammals
[10], which correspond to the genes ire-1, atf-6, and pek-1 in C.
elegans [11,12,13]. All three pathways are regulated by the ER
chaperone BiP in response to an increase in unfolded proteins [9].
Here we demonstrate that the ER stress response, in particular
the ire-1 arm, is activated upon exposure of C. elegans and
mammalian cells to PFTs. We demonstrate for the first time that
the ire-1– xbp-1 armof the UPR (and to a lesser extent the atf-6 arm)
is functionally important for defense against a pathogenic attack
sinceloss ofthis pathwayleadstoanimals hypersensitive to PFT,but
not to other toxic insults. Furthermore, we demonstrate that
activation of the ire-1-xbp-1 pathway by PFT requires p38 MAPK
and its associated MAPK kinase and that the in vivo response of the
UPR to a PFT can be separated from its response to unfolded
proteins. These results indicate that activation of the UPR plays an
important role in cellular defenses against pathogens.
Results
Cry5B activates the IRE-1 UPR pathway
In a genetic screen for genes involved in the cellular response of C.
elegansto the PFT Cry5B, we found a mutant predicted to be defective
in protein N-glycosylation in the ER (L.J.B. and R.V.A., manuscript
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UPR, this result suggested that perhaps the UPR might play a role in
protection against PFTs. To test this hypothesis, we first investigated
whether or not the UPR was activated by a PFT. The xbp-1 gene is
spliced upon activation of the IRE-1 branch of the UPR, and its
splicing is one marker for IRE-1 (and UPR) activation [13]. In C.
elegans,t h exbp-1 intron spliced by IRE-1 is 23 nucleotides and the
induction of this splicing event can be detected by RT-PCR [14]. To
analyze xbp-1 mRNA transcript splicing, animals were fed Escherichia
coli expressing Cry5B and compared to worms fed control E. coli
(Figure 1A). While there is abundant unspliced xbp-1 mRNA
transcript in both samples, there is an increase in the spliced xbp-1
transcript from worms ingesting Cry5B, indicating activation of the
IRE-1 pathway. Quantitative analyses indicate that the xbp-1 spliced
transcript increases 2.3, 3.0, and 3.0 fold at the 7, 8, and 9 h time
points respectively.
Toindependentlytestthisresult,weanalyzedtheinvivoexpression
ofanire-1 regulated gene,hsp-4, a BiP homolog. Invivoanalysis of the
hsp-4 promoter coupled to green fluorescent protein (GFP)
demonstrated expression of this gene requires ire-1 and xbp-1 [13].
A C. elegans strain containing hsp-4::GFP was fed either control E. coli
or Cry5B expressing E. coli for 8 hours at 20uC. As shown, a strong
and specific increase in GFP expression in the intestine can be seen
in the presence of the PFT (Figure 1B, middle panel), consistent with
activation of the ire-1-xbp-1 pathway by Cry5B. Heat shock of this
strain in the absence of Cry5B confirms GFP could be induced in
othercelltypes inaddition to the intestine (Figure 1B, right panel),as
was demonstrated with the N-glycosylation inhibitor tunicamycin
[13]. The fact that Cry5B only induced expression in intestinal cells
suggests the PFT is only targeting these cells (see below).
To address whether the ire-1-xbp-1 pathway is also activated in
mammalian cells in response to a PFT, activation of the pathway
was ascertained in HeLa cells exposed to the Aeromonas hydrophila
PFT, aerolysin. As detected by the presence of the spliced protein
isoform of XBP-1, treatment of mammalian cells with a PFT also
results in robust activation of the ire-1-xbp-1 pathway (Figure 1C).
The ER stress response is required for defense of C.
elegans against Cry5B
To determine whether the ER stress response played a role in
the defense of C. elegans against the PFT, C. elegans mutants in the
ER stress response pathway were qualitatively compared to wild-
type N2 animals in their susceptibilities to Cry5B. The mutants
that were tested included those encoding the three ER stress
transducer genes, atf-6(ok551), pek-1(ok275), and ire-1(v33), as well
as xbp-1(zc12); these mutations are predicted or known to be loss of
function mutations in their respective genes [11,12,13]. In the
absence of Cry5B, the wild type and mutant worms are healthy
adults with similar appearance, except ire-1(v33), which is clearly
smaller than the other strains (Figure 2A). In the presence of low-
moderate levels of the PFT Cry5B, wild-type worms are slightly
intoxicated compared to those found on control no-toxin plates, as
evidenced by their smaller sizes and paler appearances (Figure 2A).
To the same extent seen with wild-type worms, atf-6(ok551) and
pek-1(ok275) mutant animals are also slightly intoxicated on low-
moderate levels of the PFT Cry5B, indicating lack of either of
these genes does not result in overt hypersensitivity or hyper-
resistance to Cry5B (Figure 2A). However under the same
conditions, the ire-1(v33) and xbp-1(zc12) mutant worms are more
severely intoxicated than wild-type worms as they are relatively
smaller and considerably paler compared to their corresponding
no toxin controls. The hypersensitivity to Cry5B resulting from
lack of ire-1 and xbp-1 was also seen using RNA interference
(RNAi; data not shown), confirming the phenotype is caused by
loss of function in these genes. We call this hypersensitivity
phenotype ‘‘Hpo’’ for hypersensitive to pore-forming toxin.
The sensitivity to Cry5B of animals mutant for the three ER
stress response pathways was quantitatively assessed using a dose-
dependent lethality assay (Figure 2B). From these data, an LC5ss
(lethal concentrations at which 50% of the animals die) were
obtained (Table 1). Our quantitative results confirm that ire-1(v33)
and xbp-1(zc12) mutant animals are statistically more sensitive to
PFT than wild type animals (Table 1) and thus are Hpo relative to
wild type (caution is called for in interpreting the ire-1(v33) data
since many of these animals also have significant overt defects, e.g.,
developmental delays which prevents them from being as well
synchronized at the start of the assay compared to the other strains
[11]). Our results indicate that atf-6(ok551) mutant animals are
also Hpo, albeit to a lesser extent (2.8 vs. 5.8 fold increase in
sensitivity for atf-6 vs. xbp-1). Although atf-6(ok551) hypersensitivity
was not discerned with the plate assay, it is likely that the
quantitative lethality assay is a more sensitive test for Cry5B
hypersensitivity than the qualitative plate assay. In contrast to xbp-
1 and atf-6 mutant animals, the sensitivity of pek-1(ok275) mutant
animals is not statistically different from that of wild-type animals
(Table 1).
To independently confirm these results, we used a develop-
mental assay to assess the relative sensitivity of the four ER stress
response mutants to Cry5B. This experiment was performed by
placing newly hatched L1 stage worms on plates containing
different percentages of Cry5B expressing E. coli and then
counting the worms that developed to either the L4 stage or
adulthood (Figure 2C). In the absence of Cry5B, nearly all worms
developed to the L4 stage or adulthood for all strains with the
exception of ire-1(v33). This result confirms developmental defects
previously seen with this mutant [11], and it was therefore
excluded from subsequent analyses. Wild type N2 and pek-
1(ok275) were both similarly inhibited in their development by
increasing percentages of Cry5B. Compared to N2 and pek-
1(ok275) animals, though, both atf-6(ok551) and xbp-1(zc12) were
Hpo, i.e., each is more developmentally inhibited by Cry5B than
wild-type animals (Figure 2C). Because the ire-1-xbp-1 pathway has
a more discernible effect on protection against Cry5B than atf-6,
further experiments were focused on this arm of the ER stress
response.
Author Summary
Pore-forming toxins (PFTs) are bacterial toxins that form
holes at the plasma membrane of cells and play an
important role in the pathogenesis of many important
human pathogens. Although PFTs comprise an important
and the single largest class of bacterial protein virulence
factors, how cells respond to these toxins has been
understudied. We describe here the surprising discovery
that a fundamental pathway of eukaryotic cell biology, the
endoplasmic reticulum unfolded protein response (UPR), is
activated by pore-forming toxins in Caenorhabditis elegans
and mammalian cells. We find that this activation is
functionally important since loss of either of two of the
three arms of UPR leads to hypersensitivity of the nematode
to attack by PFTs. The response of the UPR to PFTs can be
separated from its response to unfolded proteins both at
the level of activation and functional relevance. The
response of the UPR to PFTs is dependent on a central
pathway of cellular immunity, the p38 MAPK pathway. Our
data show that the response of cells to bacterial attack can
reveal unanticipated uses and connections between funda-
mental cell biological pathways.
UPR and Pore-Forming Toxin Defenses
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pathway functions to protect the host against the PFT Cry5B.
However, an alternative explanation for our results is that animals
mutant in this pathway (e.g., xbp-1 mutant animals) are sickly and
have compromised health and therefore would respond poorly to
any toxic insult. To address this alternative hypothesis, we tested
whether xbp-1(zc12) animals are hypersensitive to two toxic
chemical compounds, the heavy metal CuSO4 (a toxic insult that
kills with kinetics similar to Cry5B) and the oxidative stress agent
H2O2 (a toxic insult that kills rapidly). The mutant xbp-1(zc12) has
the same sensitivity as wild type to killing by either CuSO4 or
H2O2 (Figure 2D and 2E; Table 1). These data argue against the
supposition that this mutant is hypersensitive to the PFT merely
because it is generally unhealthy. Rather, the protective response is
somewhat specific against the PFT. These conclusions are
strengthened by the finding that C. elegans lacking the UPR
respond normally to attack by the pathogenic bacteria Pseudomonas
aeruginosa, which does not make a PFT (Figure 2F and Table 1).
The xbp-1 pathway functions in the intestine to protect
against Cry5B PFT
Mosaic and expression analyses have shown that the targeting of
intestinal cells by the PFT Cry5B is both necessary and sufficient
to intoxicate worms [15,16]. If the ire-1-xbp-1 pathway is
functioning directly to protect against the effects of the PFT, then
we would predict that the ire-1-xbp-1 pathway should function in
the target cells of the toxin, the intestinal epithelial cells.
Alternatively, the pathway might be functioning indirectly to
protect against the effects of the PFT (e.g., it might hypothetically
function in neurons that then sends protective signals to the
intestine). Consistent with the first hypothesis, that the pathway is
functioning directly in the target cells to protect against the PFT,
we previously noted that a marker for downstream activation of
the pathway, hsp-4, is turned on exclusively in intestinal cells
(Figure 1B, middle panel), although the pathway is capable of
being activated throughout the worm by a more general stress,
such as heat shock (Figure 1B, right panel).
Figure 1. The IRE-1 UPR is activated in response to PFTs. (A) xbp-1 mRNA splicing is induced in wild-type C. elegans fed E. coli expressing Cry5B
compared to control E. coli not expressing Cry5B. The time the worms were allowed to feed on the E. coli before total RNA was prepared for RT-PCR is
indicated at the top, and the positions of the nucleotide size markers are indicated at the left. (B) Compared to worms fed control non-Cry5B
expressing E. coli, in vivo activation of hsp-4::GFP occurs specifically in the intestines of worms fed Cry5B expressing E. coli at 20uC for 8 hours. As a
comparison for GFP induction, separate worms on control bacteria were heat shocked at 30uC for 8 hours to induce the ER stress response by causing
unfolded proteins. The heat shock worms have a strong increase in GFP throughout the body including the head, intestine and hypodermis. Thus,
although the entire worm is capable of activating the ire-1-xbp-1 pathway as judged by hsp-4 induction, activation in Cry5B-fed animals is occurring
only in those cells targeted by the PFT. Images taken by light microscopy are compared to images with fluorescence microscopy. Scale bar is 0.2 mm.
The experiment was performed three times, and representative worms are shown. (C) Aerolysin induces activation of IRE1 in mammalians cells.
Exposure of HeLa cells to proaerolysin (2 ng/mL) leads to increased production of spliced XBP1 protein as shown on this immunoblot (upper) and
quantitated relative to no toxin control (lower). DTT (10 mg/mL for 2 h) was used as a positive control. Positions of molecular weight markers (kDa)
are indicated on right side of the figure. A nonspecific antibody-reacting band was used as a loading control and normalization of the XBP1 signal in
each lane.
doi:10.1371/journal.ppat.1000176.g001
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of ER stress response mutants to wild-type N2 on 25% Cry5B-expressing E. coli plates indicate ire-1(v33) and xbp-1(zc12) are hypersensitive to Cry5B
intoxication. Two representative worms are shown for each strain 48 hours after feeding either on E. coli without Cry5B or on E. coli of which 25%
expressed Cry5B. Scale bar is 0.2 mm. (B) A lethal concentration assay was performed using purified Cry5B toxin to quantitatively compare
sensitivities of wild-type N2 and the ER stress mutants. Lethality was determined after 8 days. This semi-log graph represents three independent
experiments, and each data point is the mean and standard deviations of the experiments. (C) A Cry5B developmental inhibition assay was performed
beginning with synchronized worms at the first larval stage. Worms were grown on plates containing different percentages of Cry5B-expressing E.
coli (% Cry5B as indicated under the figure), and the percent of worms reaching the L4 stage or adulthood 72 hours later is indicated. ire-1(v33) was
included only on the plates with 0% Cry5B. Data are presented as mean and standard deviation. (D) A lethal concentration assay comparing
sensitivity to CuSO4 revealed xbp-1(zc12) is not hypersensitive compared to wild-type N2. Lethality was determined after 8 days of CuSO4 exposure,
the same time frame as the Cry5B lethality assay. Data, plotted semi-log, are the mean and standard deviation of three independent experiments. (E)
A lethal concentration assay comparing sensitivity to H2O2 revealed xbp-1(zc12) is not hypersensitive compared to wild-type N2. Lethality was
determined after 4 hours of H2O2 exposure. Data, plotted semi-log, are the mean and standard deviation of three independent experiments. (F) A
lifespan assay was used to compare the ER stress mutants to slow killing by P. aeruginosa PA14. This graph represents combined data from three
experiments.
doi:10.1371/journal.ppat.1000176.g002
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cells against Cry5B, the intestinal specific app-1 promoter [17] was
used to drive expression of xbp-1 in xbp-1(zc12) mutant animals to
determine if expression in the intestine is sufficient to rescue the
Hpo phenotype. As a negative control, GFP was similarly
expressed under control of the app-1 promoter in xbp-1(zc12)
mutant animals. In control animals, expression of the GFP solely
in intestinal cells was confirmed (data not shown). As expected, the
majority of wild-type N2 animals showed only a low-modest
degree of intoxication upon exposure to 25% Cry5B-expressing E.
coli (Figure 3A, B; they were smaller and somewhat paler than the
wild-type worms on control plates but were still quite active). Also
as predicted, both xbp-1(zc12) mutant animals and xbp-1(zc12)
mutant animals transformed with app-1::GFP were Hpo and
intoxicated to similar extents (Figure 3A, B; most animals were
very pale, small, and inactive). In contrast, xbp-1(zc12) worms
expressing xbp-1 under the app-1 promoter were significantly
healthier than either untransformed or app-1::GFP transformed
xbp-1(zc12) animals fed with Cry5B (Figure 3A, B). However, these
app-1::xbp-1-transformed xbp-1(z12) worms were not as healthy as
wild-type N2 under the same conditions. This partial rescue could
indicate the expression of the artificial xbp-1 transgenes did not
fully recapitulate wild-type xbp-1 expression levels and/or that
there is some role for the ire-1 – xbp-1 pathway in other cell types.
Nonetheless, our results support a significant protective function
for xbp-1 within the cells targeted by Cry5B.
Induction of ire-1-xbp-1 pathway’s role in response to PFT
but not unfolded proteins is regulated by the p38 MAPK
pathway
ER stress responses have been studied extensively for their role
in protecting cells against unfolded proteins [10,18]. One way to
assess the role of the ER stress pathways in protecting against
unfolded proteins is with the drug tunicamycin (a natural
compound that leads to the accumulation of unfolded proteins
in the ER due to its inhibitory effect on N-linked protein
glycosylation [19]). Previous data in C. elegans have indicated
different sensitivities of the three ER stress response pathways for
tunicamycin [11,12]. Using a different toxicity assay, we have
confirmed these observations: atf-6(ok551) mutant animals have a
similar sensitivity to tunicamycin as wild-type animals whereas
both xbp-1(zc12) and pek-1(ok275) mutant animals are more readily
killed by tunicamycin (Figure 4). These results are in contrast to
the response of these different ER stress pathways to Cry5B, to
which atf-6 mutant animals are more sensitive than pek-1 mutant
animals. These data suggest that there are differences in how ER
stress pathways are activated in response to unfolded proteins and
to the PFT Cry5B.
Table 1. Data analysis of the Cry5B, CuSO4 and H2O2 lethal concentration assays and P. aeruginosa (PA14) lifespan assay.
Cry5B
Strain LC50 (mg/mL) Standard Deviation p value Relative Sensitivity (LC50 wild type/LC50 mutant)
Wild type (N2) 18.6 5.76
pek-1(ok275) 18.3 4.79 .0.05 1.02
atf-6(ok551) 6.70 2.53 ,0.01 2.78
xbp-1(zc12) 3.22 1.72 ,0.001 5.78
ire-1(v33) 1.40 0.59 ,0.001 13.3
CuSO4
Strain LC50 (mM) Standard Deviation p value
Wild type (N2) 3.26 0.19
xbp-1(zc12) 4.16 1.07 0.34
H2O2
Strain LC50 (mM) Standard Deviation p value
Wild type (N2) 1.20 0.21
xbp-1(zc12) 1.38 0.38 0.87
PA14
Strain Median Survival (Hrs)
Wild type (N2) 96
pek-1(ok275) 84
atf-6(ok551) 96
xbp-1(zc12) 96
Cry5B
Strain LC50 (mg/mL) Standard Deviation p value Relative Sensitivity (LC50 wild type/LC50 mutant)
Wild type (N2) 20.4 12.3
sek-1(km4) 0.12 0.054 ,0.05 170
The p value for comparison of the PA14 survival curves was p=0.05.
doi:10.1371/journal.ppat.1000176.t001
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which promotes cell survival and cellular defenses and which
seems to play a central role in cellular responses to PFTs [6,7,20].
We therefore investigated whether PFT-mediated activation of the
UPR and the p38 MAPK pathway might be connected.
We first investigated whether the ire-1-xbp-1 pathway plays a
role in the PFT-induced activation of p38 by comparing the
activation of the p38 MAPK in wild-type and xbp1(zc12) animals.
We find that addition of Cry5B to wild-type C. elegans results in an
increase in phosphorylated p38, indicating the p38 pathway is
activated by a PFT in C. elegans just as it is in mammalian cells [20]
(Figure 5A). We find that p38 activation occurs normally in xbp-
1(zc12) mutant animals (Figure 5A), indicating that the UPR is not
required for activation of p38 MAPK pathway in response to PFT.
We extended this result using ttm-2, a downstream transcriptional
target of the p38 MAPK pathway in response to Cry5B and a gene
required for normal defense against Cry5B PFT [6]. Upregulation
of ttm-2 mRNA was dependent on the p38 MAPK pathway but
not dependent on xbp-1 (Figure 5F).
We next analyzed the reverse relationship between the ire-1-xbp-
1 and the p38 MAPK pathways, namely whether the p38 MAPK
pathway is required for PFT-induced activation of the ire-1-xbp-1
pathway. We find that activation of the ire-1-xbp-1 pathway in
response to PFT is dependent on the p38 MAPK pathway, namely
on sek-1, the MAPK kinase (MAPKK) gene upstream of p38, and
on pmk-1, the p38 MAPK downstream of sek-1 (Figure 5). We find
that increased splicing (activation) of xbp-1 in response to Cry5B
does not occur in sek-1(km4) MAPKK mutant animals (Figure 5B).
Quantitatively, at the 3 h time point the spliced form of xbp-1 is
induced 1.9 fold in animals with an intact p38 MAPK pathway
and depressed 1.8 fold in sek-1(km4) MAPKK mutant animals
relative to untreated controls. However, sek-1 is not absolutely
required for splicing of xbp-1 since, in response to tunicamycin,
splicing of xbp-1 is normal in sek-1(km4) mutant animals
(Figure 5C). In agreement with these results, we find that in vivo
activation of the downstream target of the ire-1-xbp-1 pathway, hsp-
4::GFP, by Cry5B within intestinal cells does not occur in pmk-
1(km25) p38 MAPK mutant animals (Figure 5D), whereas
activation of hsp-4::GFP by tunicamycin does occur normally in
pmk-1(km25) mutant animals (Figure 5E).
To independently confirm and extend these results, we analyzed
a different downstream target of the ire-1-xbp-1 pathway. Using
proteomics, we identified a protein, Y41C4A.11 (a homolog of the
beta-prime subunit of the coatomer complex), that increased 4.6
fold in C. elegans animals exposed to Cry5B and whose increase was
completely dependent on xbp-1 (see Materials and Methods and
Protocol S1). The gene encoding this protein was previously
demonstrated to be transcriptionally regulated by tunicamycin in
an ire-1 and xbp-1 dependent manner [12]. Using real time PCR,
we find that both hsp-4 mRNA and Y41C4A.11 mRNA are
induced by either Cry5B or tunicamycin (Figure 5F). Consistent
with activation of the ire-1-xbp-1 pathway by p38 MAPK in
response to PFT but not unfolded proteins, the full induction of
both mRNAs by Cry5B, but not tunicamycin, is dependent on sek-
1 MAPKK. Interestingly, whereas induction of both mRNAs by
Cry5B is lacking in xbp-1(zc12) mutant animals (confirming that
activation of hsp-4 and Y41C4A.11 by PFT is via the UPR), both
Figure 3. Intestinal specific expression of xbp-1 is sufficient to rescue sensitivity to the PFT. Sensitivity to Cry5B was compared among
wild-type N2, xbp-1(zc12), xbp-1(zc12) transformed with app-1::GFP, and xbp-1(zc12) transformed with app-1::xbp-1 animals using a plate feeding
assay. (A) The health of the worms (details in Materials and Methods) was evaluated after 72 hours on 25% Cry5B-expressing E. coli. Three and six
independent lines of app-1::GFP and app-1::xbp-1 were used, respectively. Data are mean and standard deviation of three experiments. (B) Images
comparing the health of wild-type N2, xbp-1(zc12), xbp-1(zc-12) app-1::GFP, and xbp-1(zc-12) app-1::xbp-1 animals on 25% Cry5B plates for 72 h. Scale
bar is 0.2 mm.
doi:10.1371/journal.ppat.1000176.g003
Figure 4. The ER stress response mutants differ in their
sensitivities to tunicamycin. A lethality assay was used to compare
sensitivities of the ER stress mutants and wild-type N2 to tunicamycin.
The percent of worms alive after 8 days of exposure to each
concentration of tunicamycin was determined. Data are the mean
and standard deviation of three independent experiments.
doi:10.1371/journal.ppat.1000176.g004
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PLoS Pathogens | www.plospathogens.org 6 October 2008 | Volume 4 | Issue 10 | e1000176Figure 5. Relationship of the p38 MAPK and UPR pathways in response to PFT and unfolded proteins. (A) The xbp-1 pathway is not
required for phosphorylation of p38 MAPK by Cry5B. Wild-type N2 and xbp-1(zc12) were exposed to either control buffer or purified Cry5B toxin for
one hour. Worm lysates were analyzed by immunoblotting for phospho P38 MAPK along with a-tubulin as a loading comparison. Positions of
molecular weight markers in kilodaltons are shown on left side of gel. Data are representative of three independent experiments. (B) Cry5B induced
splicing of xbp-1 requires sek-1 (MAPKK). Splicing of xbp-1 mRNA was compared in glp-4(bn2) and glp-4(bn2);sek-1(km4) after 3 hours of exposure to
either control E. coli or E. coli expressing Cry5B. Size markers in nucleotides are indicated on the left. This is a representative experiment of three
independent experiments. (C) Tunicamycin induced splicing of xbp-1 does not require sek-1 (MAPKK). Splicing of xbp-1 mRNA was compared in glp-
UPR and Pore-Forming Toxin Defenses
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mutant, albeit at lower levels than in wild-type animals. These data
suggest that some of the UPR-mediated transcriptional response is
p38 pathway independent.
Based on these data, we predicted that animals mutant in the
p38 pathway should be more sensitive to PFT than animals
mutant in the UPR pathway. This hypothesis is based on the fact
that the p38 pathway is upstream of the UPR, is required for full
activation of the UPR in response to PFT, and is involved in UPR-
independent PFT defense pathways (e.g., ttm-2). Comparison of sek-
1(km4) and xbp-1(zc12) mutant animals on Cry5B indicates sek-
1(km4) animals are more severely intoxicated than xbp-1(zc12)
animals at the same dose of Cry5B (Figure 5G). This conclusion
was quantitatively confirmed by performing LC50 experiments on
N2 and sek-1(km4) animals (Table 1). Whereas the LC50 of xbp-
1(zc12) animals on Cry5B is 5.8 fold lower than N2, the LC50 of
sek-1(km4) animals on Cry5B is 170 fold lower than N2.
Discussion
Here we demonstrate that ER stress response pathways play a
central but heretofore unknown role in innate defenses in vivo.
Specifically, we find that bacterial pore-forming toxins (PFTs)
activate the ire-1-xbp-1 branch of the ER Unfolded Protein
Response (UPR) in C. elegans and mammalian cells and that the ire-
1-xbp-1 and atf-6, but not the pek-1, branches of the UPR are
important for C. elegans cellular defenses against a PFT since
elimination of either of these two branches leads to hypersensitivity
to the PFT Cry5B.
The ER stress response has been previously associated with
pathogenic attack, mostly in the opposite direction shown here,
e.g., aiding viral replication and pathogenesis ([21] and references
therein). In a few cases, the ER stress response has been linked
with innate immunity since induction of ER stress can activate
CREB-H, which in turn promotes the acute inflammatory
response [22]. It has also been suggested that IRE-1 could
influence immunity via its association with TRAF-2, which in turn
can regulate NF-kB [23]. Data from studies in plants suggest that
in response to pathogens, signals can be produced that lead to an
‘‘anticipatory’’ UPR to handle the massive synthesis of new
secretory proteins required [24].
Here we definitively demonstrate a functional role of the UPR
in defense against a pathogen in vivo. Loss of xbp-1 leads to animals
nearly 6 fold more susceptible to PFT whereas loss of atf-6 leads to
animals nearly 3 fold more susceptible.
Our data suggest that cells have adapted the UPR pathway for a
specific response to PFTs in order to promote cellular defense
against this common form of pathogenic attack. First, we found
that loss of the xbp-1 arm of the UPR does not lead to
hypersensitivity to a heavy metal or hydrogen peroxide nor does
loss of either xbp-1 or atf-6 lead to decreased protection against a
bacterial pathogen that lacks a PFT. Second, the ire-1-xbp-1 and
atf-6 arms of the UPR are involved in the defense but the pek-1
arm is not. Third, the activation and function of the UPR in PFT
defenses can be separated from the role of the UPR in dealing with
unfolded proteins (here tested using the drug tunicamycin) in two
ways: 1) the relative importance of the various arms of the UPR for
defense against PFT is different than their importance for
protection against unfolded proteins and 2) the activation of the
ire-1-xbp-1 pathway by PFT, but not unfolded proteins, requires
p38 MAPK (see below).
A link between the p38 and UPR pathways has been shown in
previous studies, although not with the level of functional
relevance demonstrated here. Various arms of the UPR have
been shown as both upstream or downstream of the p38 pathway,
depending on the circumstances [25,26,27,28,29,30]. The p38
pathway itself is implicated extensively in innate immune
protection of many organisms against pathogens [31] and against
PFTs in worms and mammals [6,7]. Our data presented here for
the first time functionally link the UPR to this major innate
immune signal transduction pathway. Our findings on the
activation and role of the UPR and p38 pathways in defense
against PFT are summarized in Figure 6.
Why would induction of the ER stress response play a protective
role against PFTs? It is possible that PFTs somehow lead to the
accumulation of unfolded proteins in a cell. For example, PFTs are
known to perturb calcium homeostasis and changes in calcium
homeostasis are known to affect protein folding [32,33]. In this
model, cells would respond to the toxin via p38 MAPK and turn
on the UPR to anticipate and ameliorate the detrimental effects of
unfolded proteins. Arguing against this model, however, is our
data showing that sensitivity of the three arms of the UPR to
Cry5B is different than their sensitivity to a global unfolder of ER
proteins, tunicamycin. A second model is that activation of the ER
stress response by Cry5B in a p38 MAPK dependent manner may
prepare the cell to handle an altered biosynthetic load in the ER to
defend against a toxin. For example, transcriptional array analysis
indicate that over 1000 genes are differentially regulated in C.
elegans by Cry5B ingestion [6], which could in turn lead to
significant changes in the protein load of the ER. A third model is
4(bn2) and glp-4(bn2);sek-1(km4) after 3 hours of exposure to either control (DMSO) or tunicamycin (2 mg/mL). This is a representative experiment of
three independent experiments. (D) In vivo induction of hsp-4::GFP by Cry5B requires pmk-1 (p38 MAPK). The strains hsp-4::GFP and hsp-4::GFP;pmk-
1(km25) were fed either control E. coli or E. coli expressing Cry5B for 8 hours and the expression of GFP was then analyzed. Cry5B induces GFP within
the intestinal cells of the strain hsp-4::GFP but not in the strain containing the pmk-1(km25) mutant. The experiment was performed three times and
representative worms are shown. Scale bar is 0.2 mm. (E) In vivo induction of hsp-4::GFP by tunicamycin does not require pmk-1 (p38 MAPK). The
strains hsp-4::GFP and hsp-4::GFP;pmk-1(km25) were exposed to either control (DMSO) or tunicamycin (2 mg/mL) for 8 hours and the expression of
GFP was then analyzed. Tunicamycin induces GFP throughout both the strains hsp-4::GFP and hsp-4::GFP;pmk-1(km25), including within the intestinal
cells. The experiment was performed three times and representative worms are shown. Scale bar is 0.2 mm. (F) Downstream targets of the UPR
require the p38 MAPK pathway for induction by PFT but not unfolded proteins. The fold change in the levels of hsp-4 and Y41C4A.11 mRNA
transcripts by Cry5B and tunicamycin were determined for glp-4(bn2), glp-4(bn2);xbp-1(zc12) and glp-4(bn2);sek-1(km4) using real-time PCR. In
addition, the fold change in ttm-2 transcripts was determined in response to Cry5B. Data are mean and standard deviation of three independent
experiments. (G) Animals lacking sek-1 MAPKK are more sensitive to Cry5B than animals lacking xbp-1. Wild-type N2, sek-1(km4), and xbp-1(zc12)
animals were placed on plates spread with E. coli transformed with empty vector (0%) or spread with empty vector E. coli diluted 9:1 (10%) or 3:1
(25%) with Cry5B-expressing E. coli (% thus gives toxin dose on a plate relative to undiluted Cry5B-expressing E. coli). The assay was initiated with L4
stage worms and photographs were taken 48 hours later. In the absence of Cry5B, the worms developed into dark, gravid, active, healthy adults. On
10% Cry5B-expressing E. coli, xbp-1(zc12) were slightly smaller than N2 but healthier than sek-1(km4), which were as small, pale, inactive, and severely
intoxicated. On 25% Cry5B-expressing E. coli, xbp-1(zc12) was more intoxicated than N2 but not as intoxicated as sek-1(km4) animals. Scale bar is
0.2 mm.
doi:10.1371/journal.ppat.1000176.g005
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increased phospholipid biogenesis [34]. It is possible that the
defensive role of the ire-1-xbp-1 pathway is to produce phospho-
lipids that play a protective role against PFTs. Consistent with this,
it has been shown that inhibiting the activation of SREBPs, the
central regulators of membrane biogenesis, leads to hypersensitiv-
ity of mammalian cells to the PFT aerolysin [35].
In summary, we have identified specifically the ire-1-xbp-1 and
atf-6 ER stress transducer pathways as components of cellular
defenses against a PFT. While p38 MAPK was previously
demonstrated to function in this regard [6], we have discovered
a major and unexpected downstream target of this pathway for
PFT defenses, namely the UPR. These results demonstrate the
fundamental requirement for specific cell responses to bacterial
PFTs and support the notion of intrinsic cellular defenses (or
INCED, formerly, cellular non-immune defenses), a budding
concept in immunity that emphasizes the intrinsic ability of
epithelial cells to defend against bacterial toxins and the
importance of these defenses as a supplement to the innate
immune and adaptive immune systems [36]. Additionally, the
differential importance of the three ER stress transducer pathways
in response to Cry5B versus tunicamycin, the differential
activation of ire-1-xbp-1 by p38 MAPK in response to Cry5B
versus tunicamycin, and the divergent pathways regulated by p38
MAPK in protective responses reveal how studying pathogenesis
can uncover a wonderful complexity and new connections among
intracellular pathways.
Materials and Methods
C. elegans Maintenance and Microscopy
C. elegans strains were maintained at 20uC on NG plates using
Escherichia coli strain OP50 as the food source [37]. Strains used in
this study were wild-type Bristol strain N2 [37], atf-6(ok551), glp-
4(bn2), ire-1(v33), pek-1(ok275), pmk-1(km25), sek-1(km4), SJ4005
(zcIs4 [hsp-4::GFP]) and xbp-1(zc12). atf-6(ok551) and pek-1(ok275)
were each outcrossed a total of 6 times. SJ4005 was outcrossed an
additional 4 times as it had been outcrossed twice upon receipt
from the Caenorhabditis Genetics Center. xbp-1(zc12) was created by
outcrossing strain SJ17 (xbp-1(zc12); zcIs4 [hsp-4::GFP]) four times
and removing the integrated hsp-4::GFP during the outcrosses.
Images were acquired with an Olympus BX60 microscope with
the 106 objective linked to a 0.56 camera mount and a DVC
camera. Worms were placed on 2% agarose pads containing 0.1%
sodium azide for photography.
Toxicity Assays
All assays were performed at 20uC unless indicated elsewhere.
Qualitative toxicity assays based on visual comparison of worm
intoxication were performed on plates with E. coli-expressed Cry5B
as described [6,38]. Beginning with the 4
th larval (L4) stage worms,
worms were fed for 48 hours either on control plates with E. coli
JM103 that did not expressCry5B (empty vector)or platesprepared
with E. coli JM103 expressing Cry5B diluted 1:3 with empty vector
transformed JM103. This amount of Cry5B (25%) mildly
intoxicates wild-type C. elegans, which allows for identification of
strains that are hypersensitive to Cry5B as these strains will be more
severely intoxicated than wild type. Quantitative lethal concentra-
tionassayswereperformed asdescribed [38] exceptthe wormswere
scored after 8 days for Cry5B, CuSO4, and tunicamycin. Lethal
concentration assays with H2O2 did not include E. coli or 5-fluoro-
29-deoxy-uridine, and worms were scored after 4 hours. Concen-
trations of each toxin were set-up in triplicate for each assay, and
each assay was performed independently three times. Purified
Cry5B was prepared as described [39] and dissolved in 20 mM
HEPES (pH 8.0) prior to use. Approximately 1500 worms were
scored for each strain in the calculation of the LC50 values for each
toxin. For tunicamycin assays, the set up was identical to the
lethality assay with Cry5B. For the developmental inhibition assay,
Cry5B plates werepreparedasdescribed [6,38]. Approximately100
L1 stage worms (from bleached embryos hatched off overnight)
were placed on each plate (60 mm) and the number of worms at the
L4 or adult stage 3 days later was determined. This assay was
performed independently three times. The P. aeruginosa lifespan
assay was performed on slow-killing plates as described [40], with
the following modifications: PA14 was cultured overnight in tryptic
soy broth instead of King’s broth and then spread on slow-killing
plates complemented with 75 uM mM 5-fluoro-29-deoxy-uridine.
The experiment was performed three times with approximately
100–150 worms total per strain, at 20uC. To determine if there was
rescue of the hypersensitivity phenotype in the intestinal-specific
promoter studies, 25% E. coli-expressing Cry5B plates were used to
compare Cry5B sensitivities of wild-type N2, xbp-1(zc12), and xbp-
1(zc12) that were transformed with constructs to express either
green fluorescent protein (GFP) or xbp-1 mRNA within intestinal
cells using the app-1 promoter (plasmids are described in Protocol
S1). Transgenic L4 stage worms were placed on the 25% E. coli
expressing Cry5B plates and their health status was assessed
72 hours later. Specifically, the relative health of each worm was
determined qualitatively by comparing body size, darkness of the
intestine as an indicator of feeding, and activity, including whether
the worm demonstrated spontaneous movement. For scoring of the
transgenic worms, comparisons were made using both N2 as a
reference for healthy worms, as they demonstrated dark intestines
and continuous spontaneous movement, and xbp-1 (zc12) as a
reference for intoxicated worms that had pale intestines and
demonstrated rare or no spontaneous movement.
xbp-1 splicing and real time PCR
The glp-4(bn2) strain was used for these experiments (including
the double mutants glp-4(bn2);xbp-1(zc12) an glp-4(bn2); sek-1(km4))
since it has a greatly reduced number of germ cells when grown at
Figure 6. Schematic illustrating relationship between p38
MAPK, ire-1-xbp-1, and PFT defense pathways. PFTs at the cell
surface of epithelial cells activate p38 MAPK that activates IRE-1 that
induces splicing of xbp-1, which then turns on defense against PFTs.
Residual activation of xbp-1 targets in the absence of the p38 MAPK
pathway suggests there might be p38-independent activation of the
ire-1-xbp-1 pathway in response to PFT as well (not shown).
Independent of IRE-1 activation, p38 MAPK can also activate TTM-2
and other PFT defenses. Tunicamycin, which causes the accumulation
of unfolded proteins in the ER, activates IRE-1 via a mechanism
independent of the PFT and p38 MAPK.
doi:10.1371/journal.ppat.1000176.g006
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isolated from the intestine. The response to Cry5B is not altered in
this strain compared to wild type [6]. Primers used for these
experimentsaredescribed inProtocolS1.Approximately15,000L4
stage worms were used per 100 mm dish for each treatment group.
Worms were exposed to Cry5B for the indicated period of time on
either E. coli JM103 containing empty vector or E. coli JM103
expressing Cry5B as described [6,38]. After exposure to each
treatment, worms were rinsed from plates with water, centrifuged at
500 g for 45 seconds, and washed two additional times with water.
RNA was prepared from worms using TRIZOL (Invitrogen) and
further purified with RNeasy columns (Qiagen). cDNA was
prepared by reverse transcription using oligo-dT. Standard PCR
wasused todetectxbp-1splicing,and productswere analyzed on2%
agarose gel. Unspliced xbp-1 transcript is 220 nucleotides and
spliced transcript is 197 nucleotides. To quantitate the amount of
xbp-1 splicing, loading was normalized by quantitating cDNA levels
using real time PCR and eft-2 primers [6]. Equal amounts of cDNA
wereused forthexbp-1splicing PCRexperimentsand10microliters
of each reaction were loaded onto a 2% agaose gel and stained with
ethidium bromide. NIH ImageJ was then used to quantitate the
intensities ofxbp-1splicedformsinCry5B treatedsamples relative to
untreated samples at the same time point.
Real time PCR was performed on an ABI 7000 Instrument using
SYBR Green detection (Applied Biosystems). eft-2 was used as the
real time PCR normalization control [6]. Experiments with Cry5B
used either a control plate (E. coli not expressing Cry5B) or a Cry5B
plate on which 100% of the E. coli expressed Cry5B. Tunicamycin
experimentsused E. coli OP50 asa foodsource and eitherDMSO as
the control ortunicamycin at 2 mg/mL incorporated intothe plates.
Three independent experiments for the splicing and real time PCR
were performed for each treatment.
Mammalian XBP-1 immunoblotting
HeLa cells were cultured in MEM media supplemented with
10% fetal calf serum, 1% penicillin-streptomycin, 1% glutamine
and 1% non-essential amino acids, in a humidified incubator with
5% CO2 at 37uC. Aerolysin was purified as described [41]. Cells
were continuously treated with 2 ng/mL (0.02 nM) of proaer-
olysin. At different time points, cells were washed with PBS and
lysed at 4uC in 0.25 M sucrose supplemented with proteases
inhibitor (Roche, Germany) using a needle. The whole cell
extracts were subjected to SDS-PAGE and Western blotting.
XBP1 (R-14) antibody was from Santa Cruz Inc. Band intensities
were quantified, after background removal, using ImageJ software
(NIH). The loading in each lane was normalized relative to the
intensity of a nonspecific antibody-reacting band on the blot.
p38 MAPK immunoblotting
Approximately 750 L1 stage worms were grown in a single well
of a 48 well plate containing 150 mL S media [42] and E. coli
OP50. When worms had reached the L4 to young adult stage,
glucose was added to 100 mM and either 20 mM HEPES (pH 8.0)
or Cry5B dissolved in 20 mM HEPES (pH 8.0) to give a final
concentration of 100 mg/mL was added. After one hour, worms
were removed, centrifuged, and 175 mL of media was removed.
Twenty five mLo f2 6sodium dodecyl sulfate loading buffer was
added, and worms were boiled for 5 minutes. Ten microliters of
lysate were used for immunoblotting. Monoclonal antibody to
phospho P38 MAPK (Cell Signaling Technology cat. no. 9215)
was used at 1:300 and monoclonal antibody to a-tubulin (Sigma-
Aldrich cat. no. T6199) was used at 1:4000.
Proteomics
L4 stage glp-4(bn2) and glp-4(bn2);xbp-1(zc12) worms were used
for this experiment. Approximately 80,000 worms of each strain
were used for both control and Cry5B treatments. Control plates
consisted of 100 mm plates spread with E. coli that did not express
Cry5B, while Cry5B treatments consisted of plates in which 100%
of the E. coli expressed Cry5B. Approximately 20,000 worms were
used per plate. Worms were fed on the bacteria for 6 hours at
20uC. For details of mass spectrometry, please see Protocol S1.
Data analysis
All experiments were performed a minimum of three times.
LC50 values were determined by PROBIT analysis [43]. The
lethal concentration assays are represented graphically using
nonlinear regression performed with the software GraphPad
Prism. Statistical analysis between two values was compared with
a paired t-test. Statistical analysis among three or more values was
compared with matched one way ANOVA using the Tukey post
test. Lifespan data was analyzed with Kaplan-Meier survival
curves. Statistical significance was set at p,0.05.
Supporting Information
Protocol S1
Found at: doi:10.1371/journal.ppat.1000176.s001 (0.03 MB
DOC)
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